On the one hand, both the W351A and L325A mutants of PHD1KDM5B have non-detectable binding affinities with the H3K4me0 peptide.
The results indicate that the mutated protein BbpT582A or BbpL584A exhibits higher binding affinities with the peptide than wild type (WT) Bbp273−598 protein.
Compounds 5d, 5e, and 5i found to be most potent with IC50 in the range of 0.09 0.19 μM and 0.03 0.04 μM against the Dd2 strain and 3D7 strain respectively as well as they showed good binding affinities with the residues of the active site of pf KASI/II.
Alternatively, the affinity gradient model (Ben-Efraim and Gerace 2001) suggests that transport complexes "step" through NPCs lined with FG-nucleoporins exhibiting increasing binding affinities with the cargo complexes (Fig. 4c).
Our previous results demonstrated that the specific residues located in the complementary determining regions (CDRs) of scFv anti-p17, MET100, LYS101, ASN169, HIS228, and LEU229 play a crucial role in the different binding affinities with the HIV-1 p17 variants [ 6].
From the result, the importance of the residues which highly effect by alanine scanning of scFv anti-p17 are TRP50, ASN52, GLU57, MET100, LEU185, and LYS188 whereas from pairwise decomposition energy calculation, MET100, LYS101, ASN169, HIS228, and LEU229, play a crucial role in the different binding affinities with the HIV-1 p17 variants.
The histidine has a positive charge on its imidazole functional group which brings about changes in the binding affinity with the metal nanoparticles (Flora and Pachauri 2010).
We designed a series of compounds based on a quinazoline scaffold pharmacophore model which may have high binding affinity with the p50 subunit of NF-kB.
Further, SAR and docking studies suggest that in comparison with the α,β-unsaturated derivatives, the saturated carboxylic acid derivatives had a greater binding affinity with the enzyme and thus an enhanced inhibition activity.
Furthermore, the shFcRn exhibited about 10-fold higher binding affinity with the tumor necrosis factor-α antagonists of monoclonal antibodies Infliximab and Adalimumab than that of Etanercept, providing a clue to their different serum half-lives in vivo.
